IBM Jumps 15.8% on $2B Quantum Chip Foundry Partnership
IBM (NYSE: IBM) and the U.S. Department of Commerce announced a Letter of Intent to create Anderon, America's first pure-play quantum chip foundry in Albany, New York, backed by $2 billion in total investment. IBM shares rose 15.8% on the news.
Key Numbers
IBM (NYSE: IBM) and the U.S. Department of Commerce announced a Letter of Intent to establish Anderon, America's first pure-play quantum chip foundry, in Albany, New York. The total investment is $2 billion, comprising $1 billion in CHIPS Act incentives and $1 billion in cash, intellectual property, and staff from IBM. The stock surged 15.8% following the announcement.
The Product
Anderon is a dedicated 300-millimeter quantum wafer facility designed to supply multiple customers with quantum chips. It aims to solidify the U.S. quantum ecosystem and reduce supply chain dependencies.
Pricing and Availability
Pricing details and a commercial production timeline have not been disclosed. The facility is expected to become operational within the next few years.
Competition
IBM faces competition from Google, Microsoft, and startups like Rigetti Computing and IonQ in the quantum computing space. However, the government partnership gives IBM a significant competitive edge.
Potential Impact on IBM
The project is expected to strengthen IBM's leadership in quantum computing and generate long-term revenue from chip sales and licensing. Government backing mitigates financial risks.
Frequently Asked Questions
Found this useful? Share it